Blog Nav

Monthly Archives: May 2019

Coastal Pet Authorized Dealers Reap Exclusive Rewards

Coastal Pet Products is proud to offer an exclusive package of benefits under its newly relaunched Authorized Dealer program. The platform not only rewards our top specialty retailers for their commitment, but further supports those sellers’ crucial role in connecting pet owners to the quality Coastal Pet products that make the lives—and the lives of their pets—better.

Retailers are eligible for the Authorized Dealer designation if they have a brick-and-mortar, dog and cat specialty store that stocks Coastal Pet as their primary brand of solid nylon. They also must carry at least five of eight strategic product lines, such as Circle T® leather products, Titan® cable tie-outs, Bergan® travel products, Rascals® dog toys, and Turbo® cat toys.

Pet Retailer Perks

In support of these product categories, and in recognition of the retailer’s loyalty, Coastal offers a host of marketing and training options to help Authorized Dealers drive traffic and sales. Coastal Pet Authorized Dealers reap numerous advantages and rewards, with a recently expanded list of perks.

Exclusive Benefits:

  • Product designs shoppers can’t get anywhere else, including on ecommerce sites.
  • Promotions and specials throughout the year.
  • Portal on with value-added content sellers can use to market their business in person and online, including:
    • videos
    • social media posts
    • high-resolution images
    • POP displays
    • direct-mail postcards customized with their store logo
  • Lower drop-ship minimums ($150) to qualify for pre-paid freight.
  • Business development funds for events, promos, and advertising to support converting the store and customers to new Coastal Pet lines.
  • Quarterly visits from manufacturer’s reps to further retailer knowledge of industry trends and product offerings.
  • Special recognition on Coastal’s “Where to Buy” online directory, searchable by location.

In addition, Authorized Dealers can take advantage of Coastal Pet’s selling specialist program, an in-store training unit designed to get employees engaged in the selling process. Participants learn about the products and how to assist customers in finding the right options for their pets’ specific needs, ideal for new or existing employee training. Coastal’s selling specialist program also helps staff members build confidence in and passion for their work, which can help boost both the retailer and the Coastal Pet brand.

“The Authorized Dealer program is perfectly in step with Coastal Pet Products’ reputation for quality,” says Eric Humbert, Director of Sales. “Authorized Dealers are leaders in the industry, creating true shopping experiences for customers and taking tremendous pride in their shops and offerings. They love serving the pet owner community, and we love supporting them. We truly value the opportunity to recognize and bolster their efforts.”

Retailers interested in becoming an Authorized Dealer should inquire with their manufacturer’s rep or their Coastal Pet regional sales manager. Don’t know your rep? Contact customer service at 800.321.0248 to get connected.

Seven Years of the Golden Retriever Lifetime Study

Carter Carter, Hero #2005

When Morris Animal Foundation launched its Golden Retriever Lifetime Study in 2012, the organization was taking a bold step into uncharted territory. Using the groundbreaking Framingham human heart study as a model, the Foundation design a similar study focused on canine cancer. Seven years later, the study is going strong and researchers are looking forward to the first published papers coming out later this year looking at early health outcomes.

The idea for the study was the result of a fortuitous conversation in 2008 between three key individuals: Bette Morris, long-time Foundation trustee and respected scientist; Dr. Rod Page, Professor and Director of the Flint Animal Cancer Center at Colorado State University; and Dr. Patty Olson, CEO and President of Morris Animal Foundation at the time.

Cancer was the topic of conversation. It remains the major cause of death in older dogs and, although great strides have been made in treating cancer, the conversation turned to identifying risk factors for the disease. If we could understand what leads to a higher risk for cancer, steps could be taken to remove these risks, ultimately preventing cancer from developing.

But how to do this? The best way to identify risk factors would be to follow a group of dogs prone to cancer throughout their entire lives, documenting everything: their diet, their environment and their activity. It also would mean that biologic samples – urine, blood, hair, nails and feces – would need to be routinely collected and stored.

AmberAmber, Hero #2715

The underlying genetic background of the study group would have to be well-documented. Finally, enough dogs and dedicated owners would need to be recruited and retained for more than a decade. It would be a massive undertaking – no one in veterinary medicine had ever attempted this type of study before! The Foundation accepted the challenge and moved forward with planning and fundraising. The golden retriever was selected for the study because of its high incidence of cancer, and because the popularity of the breed meant there would be lots of dogs that would qualify to participate. The first dogs were enrolled in June 2012.

Although daunting at first, the study has been a tremendous success. We enrolled our 3000th dog in March of 2015. Seven years in, we have a staggering 85% compliance rate among our study participants with almost 97% of dogs still enrolled, statistics rivaling the best seen in human medicine. Almost half a million biologic specimens have been collected and banked. We have thousands of questionnaires filled out carefully by owners and veterinarians documenting everything from diet to environment.

ButtersButters, Hero #2592

Once the study was underway, we turned to the next challenge – using our samples and data to help researchers answer important questions about canine cancer and other health issues. We have several studies in progress. Current studies include a look at the gut bacteria differences between lean and obese dogs, another is looking at the effects of inbreeding on litter size and adult stature and yet another is looking at bloodwork changes over time.  These studies are just winding up and we’re excited to see what our researchers find!

Closer to home, our staff epidemiologist, Dr. Missy Simpson, has been starting to crunch the data and looking first at the effect of early spay/neuter on health outcomes. Her particular area of interest is the interaction of timing of spay/neuter and the development of obesity. Dr. Simpson’s current project is looking at timing of spay/neuter and non-traumatic orthopedic injury.

Audi Audi, Hero #489

Unfortunately, as our cohort ages we’re seeing more cancer development. We’ve lost 60 dogs to cancer out of 131 total deaths – that’s 45% of our total losses. Lymphoma is the most common cancer diagnosed in our cohort, followed by hemangiosarcoma, which accounts for 10% of our deaths. We need at least 500 cancer diagnoses for us to make valid associations between an environmental risk factor and cancer, and we anticipate that it will take approximately 5 more years to reach this goal. It’s a long time to wait but the information we’ll get from watching this large group of dogs through their lifetime will provide invaluable information that will be used to improve the lives of dogs everywhere.

We couldn’t do this work without the veterinarians, owners and dogs enrolled in the study, and without the support of individual donors and companies like Coastal Pet Products. Thanks to all who are making the Golden Retriever Lifetime Study a going success.